Blog
RSS FeedPosted by Michael Wonder on 14 Jun 2018
Building synergy between regulatory and HTA agencies beyond processes and procedures—can we effectively align the evidentiary requirements? A survey of stakeholder perceptions
13 June 2018 - The pathway for bringing a new medicine to the market is dependent on two sequential processes: achieving ...
Posted by Michael Wonder on 16 May 2018
Patient empowerment in Europe: is no further research needed?
15 May 2018 - In economic theory, health care can be considered a clear example of ‘market failure’ caused by ...
Posted by Michael Wonder on 18 Apr 2018
Deputy Ministers call out patient engagement as key to transforming health care
17 April 2018 - The 2018 CADTH Symposium officially kicked off in Halifax with a panel of senior healthy policy ...
Posted by Michael Wonder on 15 Mar 2018
NICE Medtech Early Technical Assessment tool to form part of government grant application process for health care product developers
15 March 2018 - The Medtech Early Technical Assessment (META) tool has been selected , as an option, to form part ...
Posted by Michael Wonder on 08 Mar 2018
Patient and public involvement in early awareness and alert activities: an example from the United Kingdom
6 March 2018 - The aim of this study is to report on the experiences, benefits, and challenges of patient and ...
Posted by Michael Wonder on 05 Mar 2018
NHS prescription charges are rising – here’s how to keep them down
3 March 2016 - Here’s what you need to know about the increase – and how to get cheaper everyday medicines. ...
Posted by Michael Wonder on 30 Jan 2018
The impact of parallel regulatory-HTA scientific advice on clinical development. Assessing the uptake of regulatory and HTA recommendations.
30 January 2018 - The “Parallel regulatory-HTA scientific advice” procedure allows manufacturers to receive simultaneous feedback from both EU regulators and ...
Posted by Michael Wonder on 09 Dec 2017
Engaging with patients on health policy changes: an urgent issue
8 December 2017 - Back in the 1980s, when I was practicing as a faculty primary care physician at an academic ...
Posted by Michael Wonder on 15 Nov 2017
EMA to work with stakeholders to improve the product information for EU medicines
15 November 2017 - Stakeholder feedback sought on ongoing electronic initiatives ...
Posted by Michael Wonder on 11 Oct 2017
Statement by FDA Commissioner Scott Gottlieb on new steps by FDA to advance patient engagement in the agency’s regulatory work
11 October 2017 - The FDA is hosting a pioneering event today: the first meeting of the Patient Engagement Advisory ...
Posted by Michael Wonder on 04 Sep 2017
Bargaining with cancer patients about treatment
2 September 2017 - Doctors at Memorial Sloan Kettering Cancer Center borrowed negotiating tactics from Harvard Business School. ...
Posted by Michael Wonder on 07 Aug 2017
Promoting consumer involvement in medicine decisions welcomed
7 August 2017 - The appointment of consumer leader, Jo Watson, as the inaugural deputy chairperson of the Pharmaceutical Benefits ...
Posted by Michael Wonder on 27 Jul 2017
FDA sets inaugural meeting of first-ever patient engagement advisory committee
25 July 2017 - Imagine checking your blood sugar levels several times a day with a glucose meter to keep your ...
Posted by Michael Wonder on 20 Jul 2017
EU watchdog concerned drug agency EMA may be too close to companies
19 July 2017 - The EMA, eager to accelerate access to promising new drugs, may be getting too cosy with ...
Posted by Michael Wonder on 03 Jul 2017
SMC industry engagement event
3 July 2017 - The SMC has announced details of the next Scottish Medicines Consortium Industry Engagement Event. ...